Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588705 · ClinicalTrials.gov registry record
The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 27
- Enrollment target
NCT00588705: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00588705 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588705 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to first understand how MSKCC Clinical Genetics Service doctors talk to women with breast cancer about any genetic risks they might carry, and if they help women to think about what they might say, in turn, to their relatives, especially their daughters. A second part of the study asks women for their opinions about when and how their daughters should be told about any genetic risks. All of this will help us develop teaching methods to help our doctors improve the way they talk about genetic risk when women with breast cancer have adolescent daughters.
Interventions
- BEHAVIORAL focus group & questionaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2007-12 |
| Est. Completion | 2017-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00588705
The ClinicalTrials.gov registry entry for NCT00588705 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which focus group & questionaire is the first listed.
NCT00588705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00588705 about?
NCT00588705 is a clinical study titled "The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer". The purpose of this study is to first understand how MSKCC Clinical Genetics Service doctors talk to women with breast cancer about any genetic risks they might carry, and if they help women to think about what they might say, in turn, to their relatives, especially their daughters. A second part o...
What is the current status of trial NCT00588705?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2007-12. Estimated completion is 2017-01.
What interventions are being tested in trial NCT00588705?
The interventions under investigation include: focus group & questionaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00588705?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.